8-K: Ainos Reports First Quarter 2024 Financial Results Strategic focus on VELDONA and AI-powered point-of-care testing continues during 2024 US$9M growth capital secured in May strengthens financial position for executing growth strategy
8-K: Ainos Reports First Quarter 2024 Financial Results Strategic focus on VELDONA and AI-powered point-of-care testing continues during 2024 US$9M growth capital secured in May strengthens financial position for executing growth strategy
8-K：Ainos公佈2024年第一季度財務業績2024年繼續將戰略重點放在VELDONA和人工智能驅動的即時醫療測試上。5月獲得的900萬美元增長資本鞏固了執行增長戰略的財務狀況